Table:
begin	end	state
1	25	signal peptide
26	39	non-cytoplasmic
40	60	transmembrane
61	91	cytoplasmic
92	109	transmembrane
110	115	non-cytoplasmic
116	134	transmembrane
135	140	cytoplasmic
141	158	transmembrane
159	163	non-cytoplasmic
164	186	transmembrane
187	194	cytoplasmic
195	211	transmembrane
212	262	non-cytoplasmic
263	283	transmembrane
284	310	cytoplasmic
311	332	transmembrane
333	350	non-cytoplasmic
351	376	transmembrane
377	387	cytoplasmic
388	405	transmembrane
406	418	non-cytoplasmic

Input:
>AO353_17115 AO353_17115 leucine/isoleucine/valine transporter permease subunit
MIRNLRQALFSALLVWAVAYPVLGLKLSIAGINLEVQGATTSTLLIIAACSVLMFLRVLF
DREYTAAMRSVPKGKLIPASASNFLTLPSTQRWVIMGLIVIALVWPFFGSRGAVDIATLI
LIYVLLGLGLNIVVGLAGLLDLGYVGFYAVGAYSYALLSHYYGLSFWICLPIAGLMAATF
GFLLGFPVLRLRGDYLAIVTLGFGEIIRLFLRNLTGLTGGPNGISNIPKPSLFGLSFERT
AAEGMQTFHEFFGLTYNPVSKVVFLYLVALLLALFALFVINRLLRMPIGRAWEALREDEI
ACRALGLNPTVIKLSAFTLGACFAGFAGSFFAARQGLVTPESFTFIESATILAIVVLGGM
GSQLGVVLAAVVMILLPELMRDFSEYRMLMFGALMVLMMIWRPQGLLPMQRPHMELRK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server